Nancy Klauber-DeMore, M.D. (IMAGE)
Caption
Nancy Klauber-DeMore, M.D., led an MUSC team that developed a highly targeted antibody therapy that, by blocking a cancer-driving protein, slowed tumor growth, reduced metastasis and re-energized the immune system in preclinical models.
Credit
Medical University of South Carolina
Usage Restrictions
Use with credit to MUSC
License
Original content